CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Novartis drops $125M for Sironax’s tech to cross blood-brain barrier

Positive
AI Analysis

Summary

Novartis acquired Sironax's blood-brain barrier technology for $125 million, joining other major pharma companies investing in CNS drug delivery solutions.

Importance:7/10
Sentiment:
0.60
M&Ablood-brain-barriertechnologyCNS
Related Companies

Read the original article

Published by BioSpace on September 17, 2026 12:51 PM

Read Original